The pending sale of Madison’s Cellular Dynamics International Inc. should end the company’s nagging financial struggles and could prove to be the moment that stem cell technology came of age, emerging from a blurry vision to a period of concrete medical advances — including the laboratory production of working human organs. Read the full Milwaukee Journal Sentinel story here.